tiprankstipranks
Trending News
More News >
Longevity Health Holdings, Inc. (XAGE)
:XAGE
US Market

Longevity Health Holdings (XAGE) Price & Analysis

Compare
81 Followers

XAGE Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

16.39%0.85%1.07%81.05%
16.39% Insiders
1.07% Other Institutional Investors
81.05% Public Companies and
Individual Investors

XAGE FAQ

What was Longevity Health Holdings, Inc.’s price range in the past 12 months?
Longevity Health Holdings, Inc. lowest stock price was $2.29 and its highest was $61.77 in the past 12 months.
    What is Longevity Health Holdings, Inc.’s market cap?
    Longevity Health Holdings, Inc.’s market cap is $2.65M.
      When is Longevity Health Holdings, Inc.’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Longevity Health Holdings, Inc.’s earnings last quarter?
      Currently, no data Available
      Is Longevity Health Holdings, Inc. overvalued?
      According to Wall Street analysts Longevity Health Holdings, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Longevity Health Holdings, Inc. pay dividends?
        Longevity Health Holdings, Inc. does not currently pay dividends.
        What is Longevity Health Holdings, Inc.’s EPS estimate?
        Longevity Health Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Longevity Health Holdings, Inc. have?
        Longevity Health Holdings, Inc. has 1,003,995 shares outstanding.
          What happened to Longevity Health Holdings, Inc.’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Longevity Health Holdings, Inc.?
          Currently, no hedge funds are holding shares in XAGE

          Company Description

          Longevity Health Holdings, Inc.

          Longevity Health Holdings Inc focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.
          Similar Stocks
          Company
          Price & Change
          Follow
          180 Life Sciences
          Creative Medical Technology Holdings
          Silo Pharma
          Klotho Neurosciences
          60 Degrees Pharmaceuticals, Inc.
          Popular Stocks
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis